Published Data from Moderna COVID-19 Vaccine Trial Show 94.1 Percent Efficacy

Results from the primary analysis of the ongoing phase 3 clinical vaccine trial demonstrate efficacy in preventing symptomatic COVID-19 infections and severe illness
Source: BWH News - Category: Hospital Management Source Type: news